Formulations of Amlodipine: A Review

被引:22
作者
Sheraz, Muhammad Ali [1 ]
Ahsan, Syed Furqan [1 ]
Khan, Marium Fatima [1 ]
Ahmed, Sofia [1 ]
Ahmad, Iqbal [1 ]
机构
[1] Baqai Med Univ, Baqai Inst Pharmaceut Sci, 51 Deh Torr,Toll Plaza,Super Highway,Gadap Rd, Karachi 74600, Pakistan
关键词
D O I
10.1155/2016/8961621
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Amlodipine (AD) is a calcium channel blocker that is mainly used in the treatment of hypertension and angina. However, latest findings have revealed that its efficacy is not only limited to the treatment of cardiovascular diseases as it has shown to possess antioxidant activity and plays an important role in apoptosis. Therefore, it is also employed in the treatment of cerebrovascular stroke, neurodegenerative diseases, leukemia, breast cancer, and so forth either alone or in combination with other drugs. AD is a photosensitive drug and requires protection from light. A number of workers have tried to formulate various conventional and nonconventional dosage forms of AD. This review highlights all the formulations that have been developed to achieve maximum stability with the desired therapeutic action for the delivery of AD such as fast dissolving tablets, floating tablets, layered tablets, single-pill combinations, capsules, oral and transdermal films, suspensions, emulsions, mucoadhesive microspheres, gels, transdermal patches, and liposomal formulations.
引用
收藏
页数:11
相关论文
共 129 条
[31]   What can we do to make antihypertensive medications taste better for children? [J].
Ferrarini, Alessandra ;
Bianchetti, Alesandra A. ;
Fossali, Emilio F. ;
Fare, Pietro B. ;
Simonetti, Giacomo D. ;
Lava, Sebastiano A. G. ;
Bianchetti, Mario G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 457 (01) :333-336
[32]   Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies [J].
Fu, YR ;
Yang, SC ;
Jeong, SH ;
Kimura, S ;
Park, K .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (06) :433-475
[33]   Efficacy, safety, and palatability of RACTAB ® formulation amlodipine orally disintegrating tablets [J].
Fukui-Soubou M. ;
Terashima H. ;
Kawashima K. ;
Utsunomiya O. ;
Terada T. .
Drugs in R & D, 2011, 11 (4) :327-336
[34]  
Garg Saurabh, 2012, Sci Pharm, V80, P229, DOI 10.3797/scipharm.1106-01
[35]   Irbesartan/Amlodipine: A Review of its Use in Adult Patients with Essential Hypertension Not Adequately Controlled with Monotherapy [J].
Garnock-Jones, Karly P. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (02) :141-150
[36]   Effectiveness of Valsartan/Amlodipine Single-pill Combination in Hypertensive Patients With Excess Body Weight: Subanalysis of China Status II [J].
Ge, Beihai ;
Peng, Wenzhong ;
Zhang, Yi ;
Wen, Yuxiang ;
Liu, Cong ;
Guo, Xiaomei .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 66 (05) :497-503
[37]   Antihypertensive Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Patients with an Inadequate Response to Aliskiren Monotherapy [J].
Glorioso, Nicola ;
Thomas, Mathew ;
Troffa, Chiara ;
Argiolas, Giuseppe ;
Patel, Samir ;
Baek, Inyoung ;
Zhang, Jack .
CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) :748-755
[38]  
Gokul Ghenge, 2011, International Journal of PharmTech Research, V3, P938
[39]   DETERMINATION OF THE ABSOLUTE-CONFIGURATION OF THE ACTIVE AMLODIPINE ENANTIOMER AS (-)-S - A CORRECTION [J].
GOLDMANN, S ;
STOLTEFUSS, J ;
BORN, L .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (18) :3341-3344
[40]   The impact of chirality on the development of robust and stable tablet formulation of (S-) amlodipine besylate [J].
Hadzidedic, S. ;
Uzunovic, A. ;
Jazic, S. Sehic ;
El-Arini, S. Kocova .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2014, 19 (08) :930-941